One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Scientists have uncovered a potential link between delayed REM sleep and Alzheimer's disease. A new study shows that ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Taking longer to enter the dream phase can disrupt the ability to consolidate memories and interfere with emotion regulation.

This is the second installment in a series of stories exploring memory disorders in the Chippewa Valley. In today’s installment we look at two couples who are dealing with the realities of having a ...

Viehbacher, "Biogen") announced today that the U.S. Food and Drug ... (U.S. brand name: LEQEMBI®) intravenous (IV) maintenance dosing. LEQEMBI is indicated for the treatment of Alzheimer's ...